The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage
Open accessAbstract
Maintenance of genomic stability depends on the DNA damage response, an extensive signaling network that is activated by DNA lesions such as double-strand breaks (DSBs). The primary activator of the mammalian DSB response is the nuclear protein kinase ataxia–telangiectasia, mutated (ATM), which phosphorylates key players in various arms of this network. The activation and stabilization of the p53 protein play a major role in the DNA damage response and are mediated by ATM-dependent posttranslational modifications of p53 and Mdm2, a ubiquitin ligase of p53. p53's response to DNA damage also depends on Mdm2-dependent proteolysis of Mdmx, a homologue of Mdm2 that represses p53's transactivation function. Here we show that efficient damage-induced degradation of human Hdmx depends on functional ATM and at least three sites on the Hdmx that are phosphorylated in response to DSBs. One of these sites, S403, is a direct ATM target. Accordingly, each of these sites is important for Hdm2-mediated ubiquitination of Hdmx after DSB induction. These results demonstrate a sophisticated mechanism whereby ATM fine-tunes the optimal activation of p53 by simultaneously modifying each player in the process.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It appears that Mdmx is relatively stable compared with Mdm2 and p53 [41], presumably due to preferential ubiquitylation of the latter proteins.”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [41]
In the citing paper
“Additionally, phosphorylation of Mdm2 and Mdmx at serine residues close to the RING domain by ATM or ATM-dependent kinases leads to accelerated auto-degradation of both Mdm2 [54] and Mdmx [41,55–58], with consequent p53 accumulation and activation.”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [41]
In the citing paper
“A recent study was able to demonstrate the phosphorylation of S403 by ATM using a phosphorylation-specific antibody (Pereg et al, 2005).”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Pereg et al, 2005
In the citing paper
“S403 is in a favorable context for ATM and a recent study by Pereg et al (2005) provided direct evidence that it is an ATM target site.”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Pereg et al (2005)
Citations
Cites
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
Self-citationEnhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Self-citationHickson, I., Zhao, Y., Richardson, C. J., Green, S. J., Martin, N. M. B., Orr, A. I., Reaper, P. M., Jackson, S. P., Curtin, N. J., & Smith, G. C. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2727 · Cited by 1,220
Sensing and repairing DNA double-strand breaks
Jackson, S. P. (2002) · Carcinogenesis · doi:10.1093/carcin/23.5.687 · Cited by 1,149
Decision making by p53: life, death and cancer
Oren, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401183 · Cited by 1,085
Moll, U. M., & Petrenko, O. (2003) · PubMed · Cited by 778
ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage
Maya, R., Balass, M., Kim, S.-T., Shkedy, D., Leal, J.-F. M., Shifman, O., Moas, M., Buschmann, T., Ronai, Z., Shiloh, Y., et al. (2001) · Genes & Development · doi:10.1101/gad.886901 · Cited by 731
Self-citationMapping of the p53 and mdm-2 Interaction Domains
Chen, J., Maréchal, V., & Levine, A. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4107 · Cited by 700
Cellular Responses to DNA Damage
Norbury, C. J., & Hickson, I. D. (2001) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.367 · Cited by 656
Research works printed but not linked: 5
- Marine, J. C. & Jochemsen, A. G. (2004) Cell Cycle 3, 900–904.15254433
- Moll, U. M. & Petrenko, O. (2003) Mol. Cancer Res. 1, 1001–1008.14707283
- Ramos, Y. F., Stad, R., Attema, J., Peltenburg, L. T., van der Eb, A. J. & Jochemsen, A. G. (2001) Cancer Res. 61, 1839–1842.11280734
- 10.1128/mcb.13.7.4107-4114.1993 · DOI
- Meek, D. W. & Knippschild, U. (2003) Mol. Cancer Res. 1, 1017–1026.14707285
Cited by
Sorted by citations
Items 101–180 of 180
Roey, K. V., & Davey, N. E. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0123-9 · Cited by 29
Phosphorylation of Cyclin D1 Regulated by ATM or ATR Controls Cell Cycle Progression
Hitomi, M., Yang, K., Stacey, A. W., & Stacey, D. W. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02047-07 · Cited by 29
Edelson‐Averbukh, M., Pipkorn, R., & Lehmann, W. D. (2007) · Analytical Chemistry · doi:10.1021/ac0623991 · Cited by 28
Self-citationBiderman, L., Poyurovsky, M. V., Assia, Y., Manley, J. L., & Prives, C. L. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06150-11 · Cited by 27
Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells
Wade, M. R., Li, Y. C., Matani, A. S., Braun, S. M. G., Milanesi, F., Rodewald, L. W., & Wahl, G. M. (2012) · Oncogene · doi:10.1038/onc.2011.625 · Cited by 25
Balancing Mdm2 — a Daxx–HAUSP matter
Ronai, Z. A. (2006) · Nature Cell Biology · doi:10.1038/ncb0806-790 · Cited by 25
Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx
Lu, Z., Wan, G., Guo, H., Zhang, X., & Lu, X. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.12.014 · Cited by 25
Markey, M. P. (2010) · Frontiers in bioscience · doi:10.2741/3780 · Cited by 26
Structural basis of how stress-induced MDMX phosphorylation activates p53
Chen, X., Gohain, N., Zhan, C., Lu, W.-Y., Pazgier, M., & Lu, W. (2015) · Oncogene · doi:10.1038/onc.2015.255 · Cited by 22
p53 mRNA Metabolism Links with the DNA Damage Response
Gnanasundram, S. V., Bonczek, O., Wang, L., Chen, S., & Fåhræus, R. (2021) · Genes · doi:10.3390/genes12091446 · Cited by 27
Linking systems biology models to data: A stochastic kinetic model of p53 oscillations
Henderson, D. A., Boys, R. J., Proctor, C. J., & Wilkinson, D. J. (2018) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780198703174.013.7 · Cited by 22
MDMX acidic domain inhibits p53 DNA binding in vivo and regulates tumorigenesis
Huang, Q., Chen, L., Yang, L., Xie, X., Gan, L., Cleveland, J. L., & Chen, J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719090115 · Cited by 21
Protecting the genome from mdm2 and mdmx
Melo, A. N., & Eischen, C. M. (2012) · Genes & Cancer · doi:10.1177/1947601912454139 · Cited by 20
Mouse modelling of the MDM2/MDMX−p53 signalling axis
Tackmann, N. R., & Zhang, Y. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx006 · Cited by 21
MDM4 alternative splicing and implication in MDM4 targeted cancer therapies.
Wu, J., Lu, G., & Wang, X. (2021) · PubMed Central · Cited by 19
E2F1 and E2F3 activate ATM through distinct mechanisms to promote E1A-induced apoptosis
Hong, S., Paulson, Q. X., & Johnson, D. G. (2008) · Cell Cycle · doi:10.4161/cc.7.3.5286 · Cited by 19
El-Hamaky, A. A., El‐Hamamsy, M. H., El-Moselhy, T. F., Sharafeldin, N., & Tawfik, H. O. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117872 · Cited by 17
MDM2 oligomers: antagonizers of the guardian of the genome
Leslie, P. L., & Zhang, Y. (2016) · Oncogene · doi:10.1038/onc.2016.88 · Cited by 18
Regulation of MDM4 (MDMX) function by p76MDM2: a new facet in the control of p53 activity
Giglio, S., Mancini, F., Pellegrino, M., Conza, G. D., Puxeddu, E., Sacchi, A., Pontecorvi, A., & Moretti, F. (2010) · Oncogene · doi:10.1038/onc.2010.324 · Cited by 17
Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection
Yang, H., Zheng, Z., Zhao, L., Li, Q., & Liao, D. (2012) · Cell Cycle · doi:10.4161/cc.11.3.19052 · Cited by 18
Chromatin Ubiquitination Guides DNA Double Strand Break Signaling and Repair
Kolobynina, K. G., Rapp, A. W., & Cardoso, M. C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.928113 · Cited by 17
The key vulnerabilities and therapeutic opportunities in the USP7-p53/MDM2 axis in cancer
Saha, G., & Ghosh, M. K. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.119908 · Cited by 18
Bivalent binding of p14ARF to MDM2 RING and acidic domains inhibits E3 ligase function
Kowalczyk, D., Nakasone, M. A., Smith, B. O., & Huang, D. T. C. (2022) · Life Science Alliance · doi:10.26508/lsa.202201472 · Cited by 15
Heijkants, R. C., Teunisse, A. F. A. S., de Jong, D., Glinkina, K., Mei, H., Kiełbasa, S. M., Szuhai, K., & Jochemsen, A. G. (2022) · Cancers · doi:10.3390/cancers14184482 · Cited by 13
Self-citationThe RNA binding protein RALY suppresses p53 activity and promotes lung tumorigenesis
Hu, H., Zhao, K., Fang, D., Wang, Z., Yu, N., Yao, B., Liu, K., Wang, F., & Mei, Y. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112288 · Cited by 13
Srdanović, S., Wolter, M., Trinh, C. H., Ottmann, C., Warriner, S. L., & Wilson, A. J. (2022) · FEBS Journal · doi:10.1111/febs.16433 · Cited by 13
The MDMX Acidic Domain Uses Allovalency to Bind Both p53 and MDMX
Fenton, M. J., Borcherds, W. M., Chen, L., Anbanandam, A., Levy, R., Chen, J., & Daughdrill, G. W. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167844 · Cited by 12
Agboola, A., Banjo, A. A. F., Anunobi, C. C., Ayoade, B., Deji-Agboola, A. M., Musa, A. A., Abdel-Fatah, T. M. A., Nolan, C. C., Rakha, E. A., Ellis, I. O., et al. (2014) · PubMed · Cited by 12
Molecular Targeting of the Most Functionally Complex Gene in Precision Oncology: p53
Brown, D. W., Beatty, P. H., & Lewis, J. D. (2022) · Cancers · doi:10.3390/cancers14215176 · Cited by 13
Turinetto, V., Porcedda, P., Minieri, V., Orlando, L., Lantelme, E., Accomasso, L., Amoroso, A., Marchi, M., Zannini, L., Delia, D., et al. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.09.003 · Cited by 11
Islam, S., Dutta, P., Sahay, O., & Santra, M. K. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100511 · Cited by 12
Carr, M. I., Roderick, J. E., Zhang, H., Woda, B. A., Kelliher, M. A., & Jones, S. N. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611798114 · Cited by 11
Calpain-mediated degradation of MDMx/MDM4 contributes to HIV-induced neuronal damage
Colacurcio, D. J., Yeager, A. M., Kolson, D. L., Jordan‐Sciutto, K. L., & Akay, C. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.10.003 · Cited by 11
Mutation analysis of the MDM4gene in German breast cancer patients
Reincke, S., Govbakh, L., Wilhelm, B., Jin, H., Bogdanova, N. V., Bremer, M., Karstens, J. H., & Dörk, T. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-52 · Cited by 11
Miyagi, Y. (2011) · Oncology Reports · doi:10.3892/or.2011.1270 · Cited by 10
Turesson, I., Simonsson, M., Hermansson, I., Book, M., Sigurdadottir, S., Thunberg, U., Qvarnström, F., Johansson, K.-A., Fessé, P., & Nyman, J. (2020) · Radiation Research · doi:10.1667/rr15417.1 · Cited by 8
Targeting homologous recombination repair in cancer
Murfuni, I., & Rass, U. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803582-5.00008-5 · Cited by 8
Kemp, V., Dautzenberg, I. J. C., Cramer, S. J., Hoeben, R. C., & van den Wollenberg, D. J. M. (2018) · Gene Therapy · doi:10.1038/s41434-018-0032-9 · Cited by 6
Reichlmeir, M., Canet-Pons, J., Koepf, G., Nurieva, W., Duecker, R. P., Döring, C., Abell, K., Key, J., Stokes, M. P., Zielen, S., et al. (2023) · Cells · doi:10.3390/cells12192399 · Cited by 4
Intra molecular interactions in the regulation of p53 pathway
Chen, J. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.09.23 · Cited by 5
p53 regulation by ubiquitin and ubiquitin-like modifications
Wang, Y., Zhang, C., Wang, J., & Liu, J. (2022) · Genome Instability & Disease · doi:10.1007/s42764-022-00067-0 · Cited by 5
MDMX under stress: the MDMX-MDM2 complex as stress signals hub
de Polo, A., Vivekanandan, V., Little, J. B., & Yuan, Z.-M. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.12.18 · Cited by 4
HLA-B-associated transcript 3 (Bat3) stabilizes and activates p53 in a HAUSP-dependent manner
Zhang, R., Cui, D., Xue, T., Lang, Y., Zhang, Y., Li, L., Sun, H., Kuang, Y., Li, G., & Tang, J. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz102 · Cited by 4
Naumann, M. (2009) · Advances and Applications in Bioinformatics and Chemistry · doi:10.2147/aabc.s8211 · Cited by 3
Chapter 8 Ataxia-Telangiectasia
Crawford, T. O., & Shiloh, Y. (2007) · Blue books of neurology · doi:10.1016/s1877-184x(09)70082-6 · Cited by 3
Self-citationLongerich, T. (2014) · Der Pathologe · doi:10.1007/s00292-014-2007-y · Cited by 2
Integrating Clinical Cancer and PTM Proteomics Data Identifies a Mechanism of ACK1 Kinase Activation
Balasooriya, E. R., Madhusanka, D., López-Palacios, T. P., Eastmond, R. J., Jayatunge, D., Owen, J. J., Gashler, J. S., Egbert, C. M., Bulathsinghalage, C., Liu, L., et al. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-23-0153 · Cited by 2
Bunderson‐Schelvan, M., Erbe, A. K., Schwanke, C. M., & Pershouse, M. A. (2009) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20498 · Cited by 2
Deregulation upon DNA damage revealed by joint analysis of context-specific perturbation data
Szczurek, E., Markowetz, F. M., Gat‐Viks, I., Biecek, P., Tiuryn, J., & Vingron, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-249 · Cited by 2
Constitutive Photomorphogensis Protein1 (COP1) mediated p53 pathway and its oncogenic role
Rabbani, M. G., Hossain, S. A., Islam, K. K., & Uddin, S. N. (2014) · Biomedical Research and Therapy · doi:10.7603/s40730-014-0022-5 · Cited by 1
(2018) · Yale University Press eBooks · doi:10.2307/j.ctvqc6gvg.12 · Cited by 2
The ATM-mediated DNA-damage response
Shiloh, Y. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139046947.035 · Cited by 1
Self-citationCell Cycle Regulation and DNA Damage
Sakasai, R., & Tibbetts, R. S. (2009) · Springer eBooks · doi:10.1007/978-90-481-2561-6_5 · Cited by 1
Complex regulation of Forkhead Box O transcription factors
van den Berg, M. C. W. (2013) · Utrecht University Repository (Utrecht University) · Cited by 1
Targeting ATM/ATR in the DNA Damage Checkpoint
Ackermann, J. M., & El‐Deiry, W. S. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-274-8_4 · Cited by 1
CHK2 is Negatively Regulated by Protein Phosphatase 2A
Freeman, A. K. (2010) · Digital Commons - University of South Florida (University of South Florida)
Leandro, G. D. S. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2011.tde-26092011-113731
Small Molecules as Research Tools for Studying the Biology of the Tumour Suppressor p53
Spinnler, C. (2011) · Figshare
Modulation of p53 activities by the prolyl-isomerase PIN1 and the bromodomain protein BRD7
Tocco, F. (2008) · OpenstarTs (Univeristy of Trieste https://www.units.it/)
Molecular mechanisms of growth suppression by pharmacologically activated p53
Hedström, E. (2009) · Figshare
ATM Mediated Signaling Defends the Integrity of the Genome
Lavin, M. F., Gatei, M. H., Chen, P., Kijas, A. W., & Kozlov, S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00263-1 · Cited by 1
Modulation of p53's transcriptional function by small molecules
Nikulenkov, F. (2011) · Figshare
Lee, K., & Daoud, S. S. (2009) · The Open Proteomics Journal · doi:10.2174/1875039700902010030
The role of microRNAs in the p53 tumor suppressor pathway
Zhang, X. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3171
Increased Radioresistance and Accelerated B Cell LymphomasinMicewithMdmxMutationsthatPrevent
Wang, Y. V., Leblanc, M., Wade, M. R., Jochemsen, A. G., & Wahl, G. M. (2009)
Self-citationModulation of the Mdm2 signaling axis sensitizes triple-negative breast cancer cells to carboplatin
Tonsing-Carter, E. Y. (2014) · ProQuest Demo Repository · doi:10.7912/c2/308
IN VIVO SIGNIFICANCE OF THE MDM4 AND P73 INTERACTION DURING DEVELOPMENT AND TUMORIGENESIS
Tashakori, M. (2015) · Digital Commons-TMC (Texas Medical Center)
Rosso, M. (2015) · CUNY Academic Works (City University of New York)
Activation of the p53 Tumor Suppressor and its Multiple Roles in Cell Cycle and Apoptosis
Giono, L. E., & Manfredi, J. J. (2009) · Springer eBooks · doi:10.1007/978-3-642-02112-1_20
The role of PATZ1 transcription factor in the DNA damage response
Deniz, E. (2014) · Sabanci University
In Vivo Discoveries in MDM2-Mediated p53 Regulation
Tackmann, N. R. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/z7ta-7m83
Tran, T. T. (2018) · NORA - Norwegian Open Research Archives
Ives, R., & Gandhi, K. (2021) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.262
Chmara, J. (2016) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2016-11527
Data from Spontaneous Tumorigenesis in Mice Overexpressing the p53-Negative Regulator Mdm4
Xiong, S., Pant, V., Suh, Y., Pelt, C. S. V., Wang, Y., Valentin-Vega, Y. A., Post, S. M., & Lozano, G. (2023) · doi:10.1158/0008-5472.c.6500723
Malhab, L. J. B. (2016) · theses.fr (ABES) · doi:10.70675/a9a79207z0857z4ed5zb207z749cdceb9430
Implication de la voie p53 dans les syndromes d'insuffisance médullaire
Durand, R. (2020) · theses.fr (ABES) · doi:10.70675/6ccc120bz65f7z4c6czabf5z9bea26651b66
Metadata
- Authors
- Pereg, Y., Shkedy, D., de Graaf, P., Meulmeester, E., Edelson-Averbukh, M., Salek, M., Biton, S., Teunisse, A. F. A. S., Lehmann, W. D., Jochemsen, A. G., & Shiloh, Y.
- Affiliations
- Leiden University (NL)
- The David and Inez Myers Laboratory for Genetic Research, Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel; Department of Molecular and Cell Biology, Leiden University Medical Center, Wassenaarseweg 72, 2333 AL, Leiden, The Netherlands; and Central Spectroscopy, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-03-23
- Volume
- 102
- Issue
- 14
- Pages
- 5056-5061
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC555986
- OpenAlex
- W2002689109
- Semantic Scholar
- c63ebd3c151eb1c16e18c06118e0ac4a4083d45d
- Cited by
- 181
- References
- 37
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 4 · 2022: 7 · 2021: 4 · 2020: 4 · 2019: 5 · 2018: 7 · 2017: 3 · 2016: 12 · 2015: 7 · 2014: 12 · 2013: 10 · 2012: 11
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Minerva Foundation
- KWF Kankerbestrijding
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (R01NS031763, NS 31763)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- HDMX, MDM2, ATM, phosphorylation, DNA damage response, DNA double-strand breaks, p53, ubiquitination, proteolysis, genome stability, post-translational modification
- MeSH terms
- Ataxia Telangiectasia, Binding Sites, Cell Line, DNA Damage, DNA-Binding Proteins, Humans, Nuclear Proteins, Phosphorylation, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Transfection, Signal Transduction, Tumor Suppressor Protein p53, Mutagenesis, Site-Directed, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Tumor Suppressor Proteins, Proto-Oncogene Proteins c-mdm2, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review